WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Avalo Therapeutics revenue was $441.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $192.0k, down 22.9% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AVTX annual revenue was $441.0k, with -77.1% growth year-over-year.

AVTX past revenue growth

How has AVTX's revenue growth performed historically?

Company
-77.08%
Industry
497.69%
Market
20.68%
AVTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AVTX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AVTX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AVTX revenue history

Current Revenue
$441.0k
Current Earnings
-$35.1M
Current Profit Margin
-7,965.8%

Be the first to know when AVTX announces revenue.

AVTX Revenue History By Year

AVTX Yearly RevenueAVTX RevenueAVTX ChangeAVTX Revenue Growth
2024-12-31$441.00k-$1.48M-77.08%
2023-12-31$1.92M-$16.13M-89.34%
2022-12-31$18.05M$12.65M+234.40%
2021-12-31$5.40M-$1.30M-19.42%
2020-12-31$6.70M-$51.35k-0.76%
2019-12-31$6.75M-$278.03k-3.96%
2018-12-31$7.03M-$20.78M-74.73%
2017-12-31$27.81M$26.66M+2,312.27%
2016-12-31$1.15MN/AN/A
2015-12-31$0.00N/AN/A
2014-12-31$0.00N/AN/A
2013-12-31$0.00N/AN/A

1 of 1

Avalo Therapeutics Revenue FAQ

What was AVTX's revenue last quarter?

On Invalid Date, Avalo Therapeutics (NASDAQ: AVTX) reported Q4 2024 revenue of $192.00 thousand up 66.37% year over year. In the same quarter last year, Avalo Therapeutics's revenue was $571.00 thousand.

What was Avalo Therapeutics's revenue in 2024?

Avalo Therapeutics's annual revenue for the twelve months ending Dec 31, 2024 was $441.00 thousand, a 77.08% decrease year over year.

How much does Avalo Therapeutics make in a day?

Based on Avalo Therapeutics annual revenue for the past five years, AVTX makes an average of $17,815.34 per day.

What was Avalo Therapeutics's annual revenue growth in the past year?

As of Q2 2025, Avalo Therapeutics's revenue has grown -77.08% year over year. This is 574.77 percentage points lower than the US Biotechnology industry revenue growth rate of 497.69%. Avalo Therapeutics's revenue in the past year totaled $441.00 thousand.

How much does Avalo Therapeutics make in a year?

Avalo Therapeutics's revenue by year for the past five years is:
  • Avalo Therapeutics's revenue for the twelve months ending Dec 31, 2024 was $441.00 thousand, a 77.08% decrease year over year.
  • Avalo Therapeutics's annual revenue for Dec 31, 2023 was $1.92 million, a 89.34% decrease from 2022.
  • Avalo Therapeutics's annual revenue for 2022 was $18.05 million, a 234.4% increase from 2021.
  • Avalo Therapeutics's annual revenue for 2021 was $5.40 million, a 19.42% decrease from 2020.
  • Avalo Therapeutics's annual revenue for 2020 was $6.70 million, a 0.76% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.